Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution

NCT06120842 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract
Glaucoma
Ocular Hypertension

Interventions

DRUG: Bimatoprost Implant System (High Dose)
DRUG: Bimatoprost Implant System (Low Dose)
DRUG: Timolol Maleate Ophthalmic Solution, 0.5%
DEVICE: Commercially Available Aspheric Monofocal Non-Yellow Chromophore IOL
DEVICE: SpyGlass IOL

Sponsor

SpyGlass Pharma, Inc.